ALPANSEALPA LABORATORIES LTD· PharmaceuticalsMediumNeutral
Announced Mon, 27 Jul · 13:27 IST

Revised filing after NSE clarification query on Q4 FY26 results

ALPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

NSE sought clarification from Alpa Laboratories on its Q4 FY26 (quarter ended 31-Mar-2026) financial results under SEBI Listing Regulations. The company has submitted its response along with a revised integrated Ind AS filing via NEAPS and XBRL. The actual response content is not included in this acknowledgement notice.

Likely market impact

Investors should review the company's response for any material clarifications on Q4 results before drawing conclusions.